SJS Investment Consulting »

Atyr Pharma shares owned by SJS Investment Consulting

Quarter-by-quarter ownership of Atyr Pharma (ATYR) shares owned by SJS Investment Consulting from 13F filings

Historical chart of SJS Investment Consulting investment in Atyr Pharma

Tip: Access up to 7 years of quarterly data

All positions including Atyr Pharma held by SJS Investment Consulting consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Atyr Pharma by SJS Investment Consulting

Quarter filed Position value Share count Share price at filing
2026-03-31 $32 42 0.79

More positions owned by SJS Investment Consulting

Dimensional Etf Trust Us Core Equity 2 (DFAC)
Dimensional Etf Trust Intl Core Equity (DFIC)
Dimensional Etf Trust Ultrashort Fixed (DUSB)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Dimensional Etf Trust Short Duration F (DFSD)
Eli Lilly & Co. (LLY)
Apple (AAPL)
Vanguard Malvern Fds Strm Infproidx (VTIP)
American Centy Etf Tr Us Eqt Etf (AVUS)
American Centy Etf Tr Avantis Emgmkt (AVEM)
Hormel Foods Corporation (HRL)
NVIDIA Corporation (NVDA)
American Centy Etf Tr Avantis Total Eq (AVTM)
Dimensional Etf Trust World Ex Us Core (DFAX)
Dimensional Etf Trust Global Real Est (DFGR)

View all positions for SJS Investment Consulting

Top funds holding Atyr Pharma

FMR
Federated Investors
BlackRock
Vanguard Group
UBS Group
Vanguard Capital Management
Geode Capital Management
State Street Corporation
GSA Capital Partners
Millennium Management
Morgan Stanley
Two Sigma Investments
Susquehanna International
Rosalind Advisors
Northern Trust

View all funds holding Atyr Pharma